Literature DB >> 27909376

Completeness of Outcomes Description Reported in Low Back Pain Rehabilitation Interventions: A Survey of 185 Randomized Trials.

Silvia Gianola1, Pamela Frigerio2, Michela Agostini3, Rosa Bolotta4, Greta Castellini5, Davide Corbetta6, Monica Gasparini7, Paolo Gozzer8, Erica Guariento9, Linda C Li10, Valentina Pecoraro2, Valeria Sirtori6, Andrea Turolla3, Anita Andreano11, Lorenzo Moja5.   

Abstract

Purpose: To assess reporting completeness of the most frequent outcome measures used in randomized controlled trials (RCTs) of rehabilitation interventions for mechanical low back pain.
Methods: We performed a cross-sectional study of RCTs included in all Cochrane systematic reviews (SRs) published up to May 2013. Two authors independently evaluated the type and frequency of each outcome measure reported, the methods used to measure outcomes, the completeness of outcome reporting using a eight-item checklist, and the proportion of outcomes fully replicable by an independent assessor.
Results: Our literature search identified 11 SRs, including 185 RCTs. Thirty-six different outcomes were investigated across all RCTs. The 2 most commonly reported outcomes were pain (n=165 RCTs; 89.2%) and disability (n=118 RCTs; 63.8%), which were assessed by 66 and 44 measurement tools, respectively. Pain and disability outcomes were found replicable in only 10.3% (n=17) and 10.2% (n=12) of the RCTs, respectively. Only 40 RCTs (21.6%) distinguished between primary and secondary outcomes. Conclusions: A large number of outcome measures and a myriad of measurement instruments were used across all RCTs. The reporting was largely incomplete, suggesting an opportunity for a standardized approach to reporting in rehabilitation science.

Entities:  

Keywords:  data reporting; low back pain; outcome measures; randomized controlled trials, as topic; rehabilitation; survey

Year:  2016        PMID: 27909376      PMCID: PMC5125456          DOI: 10.3138/ptc.2015-30

Source DB:  PubMed          Journal:  Physiother Can        ISSN: 0300-0508            Impact factor:   1.037


  28 in total

1.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

2.  Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.

Authors:  Isabelle Boutron; David Moher; Douglas G Altman; Kenneth F Schulz; Philippe Ravaud
Journal:  Ann Intern Med       Date:  2008-02-19       Impact factor: 25.391

3.  Making the best match: selecting outcome measures for clinical trials and outcome studies.

Authors:  Wendy J Coster
Journal:  Am J Occup Ther       Date:  2013 Mar-Apr

4.  Trunk exercise combined with spinal manipulative or NSAID therapy for chronic low back pain: a randomized, observer-blinded clinical trial.

Authors:  G Bronfort; C H Goldsmith; C F Nelson; P D Boline; A V Anderson
Journal:  J Manipulative Physiol Ther       Date:  1996 Nov-Dec       Impact factor: 1.437

5.  Blinding in randomised trials: hiding who got what.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

6.  SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krleža-Jerić; Asbjørn Hróbjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Doré; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

7.  Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists.

Authors:  Derek Kyte; Jonathan Ives; Heather Draper; Thomas Keeley; Melanie Calvert
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  Patient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writers.

Authors:  Melanie Calvert; Derek Kyte; Helen Duffy; Adrian Gheorghe; Rebecca Mercieca-Bebber; Jonathan Ives; Heather Draper; Michael Brundage; Jane Blazeby; Madeleine King
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

9.  Developing core outcome sets for clinical trials: issues to consider.

Authors:  Paula R Williamson; Douglas G Altman; Jane M Blazeby; Mike Clarke; Declan Devane; Elizabeth Gargon; Peter Tugwell
Journal:  Trials       Date:  2012-08-06       Impact factor: 2.279

10.  OMERACT: an international initiative to improve outcome measurement in rheumatology.

Authors:  Peter Tugwell; Maarten Boers; Peter Brooks; Lee Simon; Vibeke Strand; Leanne Idzerda
Journal:  Trials       Date:  2007-11-26       Impact factor: 2.279

View more
  9 in total

1.  Evolving Trends in Physiotherapy Research Publications between 1995 and 2015.

Authors:  Tiago S Jesus; Silvia Gianola; Greta Castellini; Heather Colquhoun; Dina Brooks
Journal:  Physiother Can       Date:  2020       Impact factor: 1.037

Review 2.  Kinesio taping for rotator cuff disease.

Authors:  Silvia Gianola; Valerio Iannicelli; Edoardo Fascio; Anita Andreano; Linda C Li; Maria Grazia Valsecchi; Lorenzo Moja; Greta Castellini
Journal:  Cochrane Database Syst Rev       Date:  2021-08-08

Review 3.  Core outcome sets for research and clinical practice.

Authors:  Alessandro Chiarotto; Raymond W Ostelo; Dennis C Turk; Rachelle Buchbinder; Maarten Boers
Journal:  Braz J Phys Ther       Date:  2017-03-18       Impact factor: 3.377

4.  Effectiveness of treatments for acute and sub-acute mechanical non-specific low back pain: protocol for a systematic review and network meta-analysis.

Authors:  Silvia Gianola; Greta Castellini; Anita Andreano; Davide Corbetta; Pamela Frigerio; Valentina Pecoraro; Valentina Redaelli; Andrea Tettamanti; Andrea Turolla; Lorenzo Moja; Maria Grazia Valsecchi
Journal:  Syst Rev       Date:  2019-08-08

5.  Estimates of the mean difference in orthopaedic randomized trials: obligatory yet obscure.

Authors:  Lauri Raittio; Antti Launonen; Ville M Mattila; Aleksi Reito
Journal:  BMC Med Res Methodol       Date:  2021-03-24       Impact factor: 4.615

6.  Core outcome measurement instruments for clinical trials in nonspecific low back pain.

Authors:  Alessandro Chiarotto; Maarten Boers; Richard A Deyo; Rachelle Buchbinder; Terry P Corbin; Leonardo O P Costa; Nadine E Foster; Margreth Grotle; Bart W Koes; Francisco M Kovacs; C-W Christine Lin; Chris G Maher; Adam M Pearson; Wilco C Peul; Mark L Schoene; Dennis C Turk; Maurits W van Tulder; Caroline B Terwee; Raymond W Ostelo
Journal:  Pain       Date:  2018-03       Impact factor: 6.961

7.  Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: the need to present minimal important differences units in meta-analyses.

Authors:  Silvia Gianola; Anita Andreano; Greta Castellini; Lorenzo Moja; Maria Grazia Valsecchi
Journal:  Health Qual Life Outcomes       Date:  2018-05-15       Impact factor: 3.186

8.  Can EQ-5D-3L utility values of low back pain patients be validly predicted by the Oswestry Disability Index for use in cost-effectiveness analyses?

Authors:  Sylvia Pellekooren; Ângela J Ben; Judith E Bosmans; Raymond W J G Ostelo; Maurits W van Tulder; Esther T Maas; Frank J P M Huygen; Teddy Oosterhuis; Adri T Apeldoorn; Miranda L van Hooff; Johanna M van Dongen
Journal:  Qual Life Res       Date:  2022-01-17       Impact factor: 3.440

9.  Health-Related Quality of Life Among United States Service Members with Low Back Pain Receiving Usual Care Plus Chiropractic Care vs Usual Care Alone: Secondary Outcomes of a Pragmatic Clinical Trial.

Authors:  Ron D Hays; Zacariah K Shannon; Cynthia R Long; Karen L Spritzer; Robert D Vining; Ian D Coulter; Katherine A Pohlman; Joan A Walter; Christine M Goertz
Journal:  Pain Med       Date:  2022-08-31       Impact factor: 3.637

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.